New Prescription Starts (NPS)
New Prescription Starts (NPS) is a pharmaceutical commercial metric counting patients newly initiated on a specific drug within a period, distinct from refills. Sales and market teams use it to gauge adoption, prescriber uptake, and the impact of promotional activity.
What are New Prescription Starts (NPS)?
New Prescription Starts (NPS) is a commercial metric in the pharmaceutical industry that counts the patients who are newly initiated on a particular drug within a given period. It deliberately excludes refills, focusing instead on first-time use of the therapy.
By isolating new patients from continuing ones, NPS gives a clearer view of fresh demand for a product. It is often examined alongside refill and total prescription data to build a complete picture of how a drug is being used over time.
Why do New Prescription Starts matter commercially?
New Prescription Starts serve as a leading indicator of a drug's adoption, showing whether prescribers are actively choosing it for new patients. Sales and marketing teams watch this metric to gauge uptake and to measure the impact of promotional campaigns and field activity.
Because growth in a product often hinges on attracting new patients rather than retaining existing ones, NPS helps brand teams set strategy and target outreach. Shifts in the metric can signal competitive pressure, formulary changes, or the effect of new clinical evidence.
- new prescription starts
- what is nps pharma
- new prescription starts meaning
- nps metric
- new patient starts
- nps pharmaceutical
- new prescription starts definition